Off‐Label Initiation of Gabapentin and Valproic Acid Among Long‐Stay Nursing Home Residents With and Without Dementia

This publication has 9 references indexed in Scilit:

• Antiepileptic prescribing to persons living with dementia residing in nursing homes: A tale of two indications
  Journal of the American Geriatrics Society, 2022
• Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes
  American Journal of Psychiatry, 2022
• Validation of Claims Algorithms to Identify Alzheimer’s Disease and Related Dementias
  The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2021
• An MDS 3.0 Distressed Behavior in Dementia Indicator (DBDI): A Clinical Tool to Capture Change
  Journal of the American Geriatrics Society, 2020
• A Clinical Overview of Off-label Use of Gabapentinoid Drugs
  JAMA Internal Medicine, 2019
• Valproate preparations for agitation in dementia
  Cochrane Database of Systematic Reviews, 2018
• Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care
  Aging & Mental Health, 2017
• Chronic divalproex sodium use and brain atrophy in Alzheimer disease
  Neurology, 2011
• Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review
  International Psychogeriatrics, 2007